COVID-19 Vaccine: What is the timeline ?
Head of Macro Analysis
Summary: There are good reasons for investors to wear rose-colored glasses right now. While economic risks remain elevated due to the wave of bankruptcies that is in sight, market optimism is rightly fueled by positive vaccine news and expectations of further monetary stimulus from the Federal Reserve and the European Central Bank as early as this month. With the United Kingdom being the first country to grant emergency approval to Pfizer's coronavirus vaccine, we publish today an update on a timeline for when a vaccine might be available for the rest of the world.
UK gives vaccine go ahead - This morning, the United Kingdom has approved for use the Pfizer/Biontech Covid-19 vaccine, opening the door to the start of the vaccination campaign early next week. This is the first country to authorize a vaccine using mRNA technology (which is a new type of vaccine that transfers molecules of synthetic RNA into human cells, as opposed to DNA vaccines). The regulatory approval is still pending for the Pfizer vaccine in the European Union and the United States. The approval date is anticipated to be on 10 December in the United States when the FDA committee is due to meet to assess quality and safety of the new vaccine while it may takes a bit longer in the European Union, perhaps one or two more weeks. According to various European sources, it is expected that the European Medicines Agency will provide an opinion on conditional marketing authorization by 29 December, thereby allowing the vaccination campaign to start at some point in January next year.
Distribution information in the UK – As it is the case in other European countries, the United Kingdom will not make the vaccines mandatory and there will be no introduction of “vaccine passports” enabling holders to travel and move freely. The vaccination campaign will be in nine steps, first targeting residents in a care home for older adults and their carers, all those 80 years of age and over and frontline health and social care workers. For each individual, the vaccination process consists of a 2-dose schedule, with protection against COVID-19 being achieved 28 days after the initiation of the vaccination. Given that the United Kingdom is about to start the vaccination campaign next week, it is likely that herd immunity will be reached at the end of Q1 2021 and that almost all the population will be vaccinated by the end of Q2 2021. A new lockdown is therefore unlikely to happen next year, but the tier system (three-tier rules in England and five-tier system in Scotland) and other restrictions measures that have been recently enacted should remain in place, at least until herd immunity is achieved.
France secures 100M doses of vaccine – The French government indicated today that it has secured around 100M doses of vaccine from seven suppliers. It would make it possible to vaccinate around 50M people (over a population of 67M people), with each individual being given two doses of the vaccine. The initial plan, which is subject to change as it is widely criticized among population, is to vaccinate around 35 to 40M individuals in 2021 and the rest of the population in 2022. If confirmed, it is a very slow timeline response to the crisis. Most other developed countries seek to vaccinate almost all the population at some point next year. The first deliveries should come in mid-January, initially from AstraZeneca (around 4.4M doses) and Pfizer (3.5M doses). Other suppliers, such as Moderna, are expected to start delivery in next February.
Below, you can see the timeline for when vaccine might be available in the following countries: Australia, the EU, Japan and the USA. Based on current scenario, immunization in developed countries will happen at the latest in the third quarter, putting a definitive end to the health crisis, though economic scars might remain longer.
Estimated doses for herd immunity (around 60% of the population)
Total doses available from various suppliers
Approval date of first vaccine
Vaccination of a large part of the population
In Q1 2021
End of Dec (Pfizer)
In Q1 2021
End of Q2 2021
2 Dec (Pfizer)
End of Q2 2021
10 Dec (Pfizer)
End of Q2 2021
Sources: European Commission, UK Department of Health and Social Care, U.S. HHS, Australian Government Department of Health, Japanese Ministry of Health, Labour and Welfare.
Latest Market Insights
Outrageous Predictions 2023: The War Economy
- The constantly growing global need for energy drives the world's richest to huddle up and launch a R&D project in a size the world hasn't seen since the Manhattan Project gave the US the first atomic bomb.
French President Macron resignsThe political stalemate in France and the rise of Marie Le Pen following the 2022 elections corners President Macron, forcing him to give up on politics and resign from his position. At least for now.
Gold rockets to USD 3,000 as central banks fail on inflation mandateAs markets and central banks realise that the idea that inflation is transitory is wrong, and that prices will remain higher for longer, gold is sent through the roof, hitting a price tag of USD 3,000
EU Army forces EU down path to full unionWith continued challenges in the region and a US military that isn't aggressively enacting its former role as global policeman, the European Union agrees to create its own armed forces, bringing the whole region closer.
A country agrees to ban all meat production by 2030In an effort to become one of the global leaders on the path to net-zero emissions, one country decides to not only put a heavy tax on meat, but to ban domestic production entirely.
UK holds UnBrexit referendumFollowing a recession and domestic pressure, the United Kingdom is thrown into political turmoil that will end with a vote to wind back Brexit.
Widespread price controls are introduced to cap official inflationHistory tells us that with the war economy comes rationing and price controls. And this time is no different, as policymakers introduce strict price controls that lead to a range of unintended consequences.
OPEC+ & Chindia walk out of the IMF, agree to trade with new reserve assetSanctions against Russia have caused widespread turmoil due to US Dollar moves in countries across the globe that don't consider the US an ally. To relieve themselves from this, they leave the IMF and create a new reserve asset.
USDJPY fixed to the USD at 200 as Japan overhauls financial systemFollowing the challenges that faced the Japanese Yen in 2022, the Bank of Japan attempts to keep the currency from sliding. Unsuccessful on the long-term, Japan will launch a reset of its entire financial system.
Tax haven ban kills private equityWith the war economy comes an increased focus on national interests and sovereign nations' ability to assert themselves. In that regard, the OECD countries turn their attention on tax havens and pull the big guns out, banning them altogether.